Bill > HR3674

This bill authorizes United States participation in the Davos Alzheimer's Collaborative (DAC), a public-private-patient initiative aimed at addressing the global challenge of Alzheimer's disease and dementia. The legislation highlights the growing worldwide impact of these conditions, noting that nearly 60 million people are currently affected, with projections of 150 million cases by 2050, and annual global economic costs exceeding $1.3 trillion. The bill establishes a U.S. policy to lead global cooperative efforts in combating Alzheimer's, particularly in low- and middle-income countries where the majority of cases are expected to occur. It allows the President to designate a representative to serve on DAC's Advisory Council and potentially its Board of Directors, with the stipulation that this individual should have expertise in development and public health. The bill authorizes U.S. contributions to DAC, with a matching requirement that limits U.S. government contributions to no more than 33 percent of total funds during fiscal years 2026-2030. Additionally, the President is required to submit annual reports to congressional committees detailing U.S. financial contributions, governance participation, and how involvement with DAC supports existing U.S. strategies for addressing Alzheimer's and promoting global health.

Military Affairs and Security

https://www.congress.gov/bill/119th-congress/house-bill/3674/all-info